LOADING
Comparing Merck & Company (MRK) and Coca-Cola Company (KO) across the Health Care and Consumer Staples sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MRK | KO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $295.4B | $345.5B |
| P/E Ratio | 33.7 | 25.0 |
| Forward P/E | 23.6 | 24.4 |
| PEG Ratio | 5.56 | 4.07 |
| EPS | $3.55 | $3.21 |
| Revenue Growth (YoY) | 4.9% | 12.1% |
| Profit Margin | 13.6% | 27.8% |
| Return on Equity | 18.9% | 43.4% |
| Dividend Yield | 2.84% | 2.59% |
| Beta | 0.22 | 0.35 |
| 52-Week High | $123.33 | $83.50 |
| 52-Week Low | $74.18 | $64.04 |
| Volume | -- | -- |
Coca-Cola Company is the larger company by market capitalization. Coca-Cola Company trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Merck & Company offers a higher dividend yield for income investors. Coca-Cola Company has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.